Loading...

HBIO HARVARD BIOSCIENCE INC Management Changes 8-K Filing

HRVR

HB

HARVARD BIOSCIENCE INC

(HBIO)

2025 8-K

Corporate Update

Financial Results Announced

Management Changes

Stock Split Approved

Financial Results Update

Operational Changes

By-law Amendment

Investor Update

Loan Agreement Details

Credit Agreement Update

Financial Results Announced

Nasdaq Compliance Update

Board Appointment

Management Change

Notice of Delisting

Financial Statements

Director Departure

Delisting Notice

Financial Results

Credit Agreement Amendment

Financial Results

Annual Meeting of Stockholders

Credit Agreement Amendment

Compensation Committee Appr...

Financial Results Announcement

Financial Condition and Res...

Appointment of CFO

Annual Meeting of Stockholders

Compensation Committee Appr...

Financial Results Announcement

Resignation of CFO

External Links:

On September 5, 2025, Harvard Bioscience Inc. appointed Stephen DeNelsky to its Board of Directors, with a compensation package valued at approximately $135,000, including equity and cash. This event is significant for the company as it brings in a director with extensive healthcare industry experience.

AI Assistant

HARVARD BIOSCIENCE INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.